Karl Verpoort

528 total citations
10 papers, 370 citations indexed

About

Karl Verpoort is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Karl Verpoort has authored 10 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Karl Verpoort's work include Cancer Genomics and Diagnostics (3 papers), Cancer Cells and Metastasis (3 papers) and Neutropenia and Cancer Infections (2 papers). Karl Verpoort is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Cancer Cells and Metastasis (3 papers) and Neutropenia and Cancer Infections (2 papers). Karl Verpoort collaborates with scholars based in Germany, Austria and Sweden. Karl Verpoort's co-authors include Birte Friedrichs, Markus Tiemann, Norbert Schmitz, Michael Wenger, Hans Salwender, Tobias M. Gorges, Klaus Pantel, Volkmar Müller, Vendula Novosadová and Oliver Mauermann and has published in prestigious journals such as Scientific Reports, Clinical Chemistry and Journal of Proteome Research.

In The Last Decade

Karl Verpoort

10 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl Verpoort Germany	7	222	123	98	65	64	10	370
Valentina Zanfagnin United States	12	182 0.8×	47 0.4×	54 0.6×	28 0.4×	76 1.2×	24	470
Melinda Laine Hsu United States	11	214 1.0×	111 0.9×	44 0.4×	25 0.4×	160 2.5×	28	422
Nancy Nixon Canada	10	233 1.0×	85 0.7×	43 0.4×	16 0.2×	64 1.0×	26	348
Barbara Jezeršek Novaković Slovenia	12	164 0.7×	98 0.8×	24 0.2×	37 0.6×	45 0.7×	43	400
Shiven B. Patel United States	12	276 1.2×	61 0.5×	41 0.4×	46 0.7×	106 1.7×	47	420
Susana Vives Spain	10	209 0.9×	76 0.6×	68 0.7×	231 3.6×	272 4.3×	37	791
Michael Paulussen Germany	8	165 0.7×	131 1.1×	29 0.3×	24 0.4×	63 1.0×	14	460
Jindřich Kopecký Czechia	13	227 1.0×	62 0.5×	79 0.8×	16 0.2×	106 1.7×	57	474
Padma Sheila Rajagopal United States	8	197 0.9×	23 0.2×	80 0.8×	26 0.4×	96 1.5×	36	539
Jeffrey B. Hargis United States	10	279 1.3×	37 0.3×	46 0.5×	37 0.6×	175 2.7×	16	476

Countries citing papers authored by Karl Verpoort

Since Specialization

Citations

This map shows the geographic impact of Karl Verpoort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Verpoort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Verpoort more than expected).

Fields of papers citing papers by Karl Verpoort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Verpoort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Verpoort. The network helps show where Karl Verpoort may publish in the future.

Co-authorship network of co-authors of Karl Verpoort

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Verpoort. A scholar is included among the top collaborators of Karl Verpoort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Verpoort. Karl Verpoort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Bartkowiak, Kai, Stefan Werner, Antje Andreas, et al.. (2025). Discovery of a sushi domain-containing protein 2-positive phenotype in circulating tumor cells of metastatic breast cancer patients. Scientific Reports. 15(1). 3913–3913. 2 indexed citations

Bartkowiak, Kai, Marcel Kwiatkowski, Antje Andreas, et al.. (2023). Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1. Journal of Proteome Research. 22(4). 1213–1230. 6 indexed citations

Bartkowiak, Kai, Isabel Heidrich, Marcel Kwiatkowski, et al.. (2021). Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells. Cancers. 13(3). 563–563. 9 indexed citations

Gorges, Tobias M., Andra Kuske, Katharina Röck, et al.. (2016). Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells. Clinical Chemistry. 62(11). 1504–1515. 117 indexed citations

Gascón, Pere, Hans Tesch, Karl Verpoort, et al.. (2013). Clinical experience with Zarzio® in Europe: what have we learned?. Supportive Care in Cancer. 21(10). 2925–2932. 88 indexed citations

Verpoort, Karl & Thomas Möhler. (2012). A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre. Therapeutic Advances in Medical Oncology. 4(6). 289–293. 22 indexed citations

Moehler, Markus, Karl Verpoort, Christoph Maintz, et al.. (2010). Efficacy and Safety of Irinotecan-Based Chemotherapy for Advanced Colorectal Cancer outside Clinical Trials: An Observational Study. Onkologie. 33(12). 684–690. 3 indexed citations

Verpoort, Karl, et al.. (2009). 3034 CORRECT, a web-based, observational study, showing that darbepoetin alfa is effective in treating chemotherapy-induced anaemia and improves quality of life in patients with breast or colorectal cancer. European Journal of Cancer Supplements. 7(2). 185–186. 1 indexed citations

Friedrichs, Birte, Markus Tiemann, Hans Salwender, et al.. (2006). The effects of rituximab treatment during pregnancy on a neonate.. PubMed. 91(10). 1426–7. 106 indexed citations

10.

Laack, Eckart, Heinz Dürk, W. Zeller, et al.. (2002). Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer. Lung Cancer. 36(3). 303–307. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact